Skip to main content
OpenTrials
Completed

NCT Number: NCT02954731

Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder

Transdiagnostic Cognitive Behavior Therapy (CBT) delivered in the individual format, have been proven just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) to make it applicable as group therapy in Danish Mental Health Service and a naturalistic trial of this manual has shown promising results. As the use of one manual instead of several diagnosis specific manuals in regional clinics could simplify logistics and reduce waiting time, the investigators want to compare group UP-CBT with diagnosis specific group CBT.

Method: A partial blinded, pragmatic, non-inferiority, multicentre randomized clinical trial (RCT). UP-CBT is compared to treatment-as-usual CT. 124 patients are included in each intervention arm, recruited from three Danish regional Mental Health Service Clinics. 31st July 2018 suppl: Inclusion number expanded to 170 in each arm due to unexpected large drop-out.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Psychotherapeutic Unit, Mental Health Centre Copenhagen, Copenhagen, Capital Region, Denmark

Loading trial locations.

About this study

Background: Transdiagnostic Cognitive Behavior Therapy (TCBT) Manuals delivered in individual format, have been reported to be just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) developed by Barlow and colleagues for use in Mental Health Service (MHS), and shown effects comparable to traditional CBT in a naturalistic trial. As the use of one manual instead of several diagnosis-specific manuals could simplify logistics, reduce waiting time, and increase therapist expertise compared to diagnosis specific CBT, the study aim to test the relative efficacy of group UP-CBT and diagnosis specific group CBT.

Methods/design: It is a partially blinded, pragmatic, non-inferiority, parallel, multi-center randomized controlled trial (RCT) of UP-CBT vs diagnosis specific CBT for depression, social anxiety disorder and agoraphobia/panic disorder. In both arms, the intervention consists of weekly group session for 14 weeks. In total, 248 patients are recruited from three regional MHS centers across the country and included in two intervention arms.31st July 2018 suppl: Inclusion number expanded to 340 due to unexpected large drop-out.

Outcomes are measured at end of therapy and at 6 months follow-up. Weekly patient-rated outcomes and group evaluations are collected for every session. Outcome assessors, blind to delivered intervention, will perform the observer-based symptom ratings, and fidelity assessors will monitor manual adherence.

Discussion: The current study will be the first RCT investigating the dissemination of the UP in a MHS setting and UP delivered in groups and including patients with depression. Hence the results are expected to add substantially to the evidence base for rational group psychotherapy in MHS. The planned moderator and mediator analyses could spur new hypotheses about mechanisms of change in psychotherapy and the association between patient characteristics and treatment effect.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Referred to Danish Mental Health Service

  • a principal DSM-5 diagnosis of Unipolar Depression (single episode or recurrent)(app. 50%), Social Anxiety Disorder (app. 25%), and Agoraphobia/Panic Disorder (app 25%)
  • the patient is currently not using any antidepressants or use accepted antidepressants (according to predefined list), which have been unchanged for at least 4 weeks before inclusion and no change in antidepressants is anticipated,
  • sufficient knowledge of the Danish language.

Exclusion criteria

  • risk of suicide is high according to clinicians or assessment researchers
  • alcohol or drug dependence,
  • cluster A or B (DSM-5) personality disorder diagnosed by intake clinicians or assessment researcher,
  • co-morbidity of pervasive developmental disorder, psychotic disorders, eating disorders, bipolar disorder, or severe physical illness,
  • psychopharmacological treatment other than those predefined as acceptable,
  • patient does not accept to stop the use of anxiolytics within the first four weeks of intervention.

Treatment and study plan

UP-CBT

Behavioral

Psychotherapy in groups based on the "Unified Protocol" a third generation CBT-type psychotherapy

Standard-CBT

Behavioral

Psychotherapy in groups based on diagnosis specific, manualized, cognitive behavior therapy

Primary outcomes

  1. WHO Well-Being Index (WHO-5)

    Time frame: Week 19 after allocation

    Self-rating questionnaire, 5 items on positive quality of life, web-based

Secondary outcomes

  1. Hopkins Symptom Check List (SCL-25)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  2. Work and Social Adjustment Scale (WSAS)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  3. Hamilton Depression Rating Scale (HDRS)

    Time frame: Week 19 after allocation

    6-item HDRS based on telephone interview

  4. Hamilton Anxiety Rating Scale (HARS)

    Time frame: Week 19 after allocation

    6-item HARS based on telephone interview

Other outcomes

  1. Overall Anxiety Severity and Impairment Scale (OASIS)

    Time frame: Weekly, weeks 4-19 after allocation, before session

    Validated questionnaire

  2. Overall Depression Severity and Impairment Scale (ODSIS)

    Time frame: Weekly, weeks 4-19 after allocation, before session

    Validated questionnaire

  3. WHO Well-Being Index (WHO-5)

    Time frame: Weekly, weeks 4-19 after allocation, before session

    Validated questionnaire

  4. Positive Affect and Negative Affect Schedule (PANAS)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  5. Positive Affect and Negative Affect Schedule (PANAS)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  6. Hopkins Symptom Check List (SCL-25)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  7. Emotion Regulation Questionnaire (ERQ)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  8. Emotion Regulation Questionnaire (ERQ)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  9. WHO Well-Being Index (WHO-5)

    Time frame: Week 42-43 after allocation

    Self-rating questionnaire, 5 items on positive quality of life, web-based

  10. Emotion Regulation Strategies Questionnaire (ERSQ)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  11. Emotion Regulation Strategies Questionnaire (ERSQ)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  12. Perseverative Thinking Questionnaire (PTQ)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  13. Perseverative Thinking Questionnaire (PTQ)

    Time frame: Week 42-43 after allocation

    Validated questionnaires - web-based

  14. Becks Depression inventory (BDI-II)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  15. Becks Depression inventory (BDI-II)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  16. Work and Social Adjustment Scale (WSAS)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  17. Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  18. Personality Inventory for DSM-5 - Short Form (PID-5 SF) Negative Affectivity and Detachment domain scores

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  19. Liebowitch Social Anxiety Scale (LSAS)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  20. Liebowitch Social Anxiety Scale (LSAS)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  21. Panic Disorder Severity Scale (PDSS)

    Time frame: Week19 after allocation

    Validated questionnaire - web-based

  22. Panic Disorder Severity Scale (PDSS)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  23. Mobility Inventory for Agoraphobia (MIA)

    Time frame: Week 19 after allocation

    Validated questionnaire - web-based

  24. Mobility Inventory for Agoraphobia (MIA)

    Time frame: Week 42-43 after allocation

    Validated questionnaire - web-based

  25. Hamilton Depression Rating Scale

    Time frame: Week 42-43 after allocation

    6-item HDRS based on telephone interview

  26. Hamilton Anxiety Rating Scale

    Time frame: Week 42-43 after allocation

    6-item HARS based on telephone interview

  27. Client Satisfaction Questionnaire

    Time frame: Week 43

    8-item validated questionnaire, web-based

  28. Patient Evaluation of Group Therapy

    Time frame: Week 19

    Purpose-made questionnaire

  29. Group Questionnaire - brief

    Time frame: Weekly, weeks 4-19 after allocation, after session

    8 items from validated questionnaire about group atmosphere

  30. Therapist Ratings of session methods and atmosphere

    Time frame: Weekly, weeks 4-19 after allocation, after session

    Purpose-made questionnaire

  31. Homework and Event Tracker

    Time frame: Weekly, weeks 4-19 after allocation, before session

    Purpose-made question for patients about homework and events previous week

Sponsors and collaborators

Lead sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Other

Collaborators

  • Aarhus University Hospital
  • Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
  • University of Copenhagen

Registry information

Official study title

Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder: A Pragmatic, Multicenter Non-inferiority Randomized Controlled Trial

Acronym: TRACT-RCT

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Nov 3, 2016
Registry last updated
Sep 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.